Bipartisan Bill Could Increase Prescription Drug Competition and Lower Prices

Congress is considering bipartisan legislation that could make lower-priced generic drugs available more quickly. In a post on To the Point, former congressman Henry Waxman and colleagues explain that the CREATES Act, to be included in an upcoming bill to fund the federal government, tackles one of the key drivers of high drug prices — drug manufacturers’ use of anticompetitive tactics to block access to generic medications.